BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7682540)

  • 1. Patterns of cytokeratin expression by neoplastic and non-neoplastic epithelium.
    Mortimer G; Jones DN; Assaf H; al-Ahmadi T
    Ir J Med Sci; 1993 Mar; 162(3):77-81. PubMed ID: 7682540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours.
    Chu PG; Lyda MH; Weiss LM
    Histopathology; 2001 Jul; 39(1):9-16. PubMed ID: 11454039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of cytokeratin proteins in squamous and transitional cell lesions of the urinary tract.
    Tungekar MF; Gatter KC; Al-Adnani MS
    J Clin Pathol; 1988 Dec; 41(12):1288-96. PubMed ID: 2465317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex cytokeratin polypeptide patterns observed in certain human carcinomas.
    Moll R; Krepler R; Franke WW
    Differentiation; 1983; 23(3):256-69. PubMed ID: 6189757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus.
    Lam KY; Loke SL; Shen XC; Ma LT
    Virchows Arch; 1995; 426(4):345-9. PubMed ID: 7541275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of cytokeratin and involucrin expression in squamous cell carcinomas of the skin during progression to malignancy.
    Watanabe S; Ichikawa E; Takahashi H; Otsuka F
    Br J Dermatol; 1995 May; 132(5):730-9. PubMed ID: 7539622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
    Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
    Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin intermediate filament expression in benign and malignant breast disease.
    Heatley M; Maxwell P; Whiteside C; Toner P
    J Clin Pathol; 1995 Jan; 48(1):26-32. PubMed ID: 7535804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratins of normal epithelia and some neoplasms of the female genital tract.
    Moll R; Levy R; Czernobilsky B; Hohlweg-Majert P; Dallenbach-Hellweg G; Franke WW
    Lab Invest; 1983 Nov; 49(5):599-610. PubMed ID: 6195450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin.
    Nagy N; Hoyaux D; Gielen I; Schäfer BW; Pochet R; Heizmann CW; Kiss R; Salmon I; Decaestecker C
    Histol Histopathol; 2002 Jan; 17(1):123-30. PubMed ID: 11813862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines.
    Blobel GA; Moll R; Franke WW; Vogt-Moykopf I
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(4):407-29. PubMed ID: 6203212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the cytokeratin marker CAM 5.2 in cervical neoplasia.
    Raju GC
    Histopathology; 1988 Apr; 12(4):437-43. PubMed ID: 2453439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin and vimentin expression in normal epithelium and benign lesions of the vocal cords.
    van der Velden LA; Schaafsma HE; Manni JJ; Link M; Ruiter DJ; Ramaekers FC; Kuijpers W
    Acta Otolaryngol; 1996 Mar; 116(2):325-31. PubMed ID: 8725542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical Cluster Analysis of Cytokeratins and Stem Cell Expression Profiles of Canine Cutaneous Epithelial Tumors.
    Kok MK; Chambers JK; Ong SM; Nakayama H; Uchida K
    Vet Pathol; 2018 Nov; 55(6):821-837. PubMed ID: 30071783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of stratified squamous epithelia-type cytokeratin by canine mammary epithelial cells during tumorigenesis: type I (acidic) 57 kilodalton cytokeratin could be a molecular marker for malignant transformation of mammary epithelial cells.
    Arai K; Kaneko S; Naoi M; Suzuki K; Maruo K; Uehara K
    J Vet Med Sci; 1994 Feb; 56(1):51-8. PubMed ID: 7515697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomiasis-associated squamous lesions of the bladder. Expression of low molecular weight cytokeratin proteins.
    Tungekar MF; Al Adnani MS; Gatter KC
    Br J Urol; 1987 Nov; 60(5):423-7. PubMed ID: 2447994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cytokeratin expression in primary and metastatic carcinomas. Diagnostic application in surgical pathology.
    Shah KD; Tabibzadeh SS; Gerber MA
    Am J Clin Pathol; 1987 Jun; 87(6):708-15. PubMed ID: 2438926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma.
    Plumb SJ; Argenyi ZB; Stone MS; De Young BR
    Am J Dermatopathol; 2004 Dec; 26(6):447-51. PubMed ID: 15618924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
    Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.